AG
AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
SEC filingBiotechnology · Rockville, MD
Amount raised$310Ksold at filing
Total offering$10M$9.7M still open
Investors in the raise4count reported to the SEC
FiledDec 22, 2025first sale Nov 3, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
William Drew PalinExecutive Officer, Director
Jeffrey Adam GalvinExecutive Officer, Director
Barry Haden WellsDirector
Executive officers, directors and promoters as listed on the Form D.